We narrowed to 18,523 results for: MUT

1. EcNGRfEfC-R10S1C9

   Bacterial Strain

   #48901

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

2. EcNGRfEfC-R10S1C10

   Bacterial Strain

   #48902

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

3. EcNGRfEfC-R10S1C11

   Bacterial Strain

   #48903

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

4. EcNGRfEfC-R10S1C12

   Bacterial Strain

   #48904

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

5. EcNGRfEfC-R10S1E7

   Bacterial Strain

   #48905

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

6. EcNGRfEfC-R10S1E8

   Bacterial Strain

   #48906

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

7. EcNGRfEfC-R10M1B10

   Bacterial Strain

   #48907

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

8. EcNGRfEfC-R10S1B9

   Bacterial Strain

   #48895

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

9. EcNGRfEfC-R10S1C2

   Bacterial Strain

   #48896

   Purpose

   diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

   Depositor

   George Church

   Bacterial Resistance

   Spectinomycin

   Available Since

   Dec. 3, 2014

   Availability

   Academic Institutions and Nonprofits only

10. EcNGRfEfC-R10S1C5

    Bacterial Strain

    #48897

    Purpose

    diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

    Depositor

    George Church

    Bacterial Resistance

    Spectinomycin

    Available Since

    Dec. 3, 2014

    Availability

    Academic Institutions and Nonprofits only

11. EcNGRfEfC-R10S1C6

    Bacterial Strain

    #48898

    Purpose

    diversity was introduced via homologous recombination to 40 sites to improve fatty acid production. Sequencing of the strains at these sites is ongoing.

    Depositor

    George Church

    Bacterial Resistance

    Spectinomycin

    Available Since

    Dec. 3, 2014

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-hSyn-hChR2(H134R)-EYFP (AAV PHP.eB)

    Viral Prep

    #26973-PHPeB

    Purpose

    Ready-to-use AAV PHP.eB particles produced from pAAV-hSyn-hChR2(H134R)-EYFP (#26973). In addition to the viral particles, you will also receive purified pAAV-hSyn-hChR2(H134R)-EYFP plasmid DNA. hSyn-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    Syn

    Tags

    EYFP

    Available Since

    Sept. 8, 2020

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-hSyn-hChR2(H134R)-EYFP (AAV Retrograde)

    Viral Prep

    #26973-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-hSyn-hChR2(H134R)-EYFP (#26973). In addition to the viral particles, you will also receive purified pAAV-hSyn-hChR2(H134R)-EYFP plasmid DNA. hSyn-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    Syn

    Tags

    EYFP

    Available Since

    Oct. 9, 2019

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-CaMKIIa-hChR2(H134R)-mCherry (AAV Retrograde)

    Viral Prep

    #26975-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-CaMKIIa-hChR2(H134R)-mCherry (#26975). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-mCherry plasmid DNA. CamKIIa-driven, humanized channelrhodopsin H134R mutant fused to mCherry for optogenetic activation. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    CaMKII

    Tags

    mCherry

    Available Since

    Dec. 2, 2019

    Availability

    Academic Institutions and Nonprofits only

15. pLY70

    Plasmid

    #130948

    Purpose

    A CRISPR activation device with the necessary genes (dxcas9 controlled by Ptet, pspFΔHTH::λN22plus controlled by promoter PrhaB), and the reporter part (PpspA-LEA3B3 with sfgfp::ASV).

    Depositor

    Baojun Wang

    Article

    Liu et al Nat Commun. 2019 Aug 26;10(1):3693. doi:

    Inserts

    dxcas9 (3.7)
    tetR
    rhaS
    pspFΔHTH::λN22plus
    sfgfp
    

    Use

    Synthetic Biology

    Tags

    ASV tag and pspFΔHTH::λN22plus

    Expression

    Bacterial

    Mutation

    Mutations D10A and H840A on WT cas9 for dCas9; Sy…

    Promoter

    Pcon, PpspA-LEA3B3, PrhaB, and Ptet

    Available Since

    Sept. 23, 2019

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

16. pLY61

    Plasmid

    #130928

    Purpose

    A CRISPR activation device with the necessary genes (dxcas9 3.7 controlled by Ptet, pspFΔHTH::λN22plus controlled by promoter J23106), and the reporter part (PpspA-LEA1B1 with sfgfp::ASV).

    Depositor

    Baojun Wang

    Article

    Liu et al Nat Commun. 2019 Aug 26;10(1):3693. doi:

    Inserts

    dxcas9 (3.7)
    tetR
    pspFΔHTH::λN22plus
    sfgfp
    

    Use

    Synthetic Biology

    Tags

    ASV tag and pspFΔHTH::λN22plus

    Expression

    Bacterial

    Mutation

    Mutations D10A and H840A on WT cas9 for dCas9; Sy…

    Promoter

    Anderson promoter: J23106, PpspA-LEA1B1, and Ptet

    Available Since

    Sept. 23, 2019

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

17. pBD-PYR1-DSM_Hao_library

    Pooled Library

    #241289

    Purpose

    Library of pBD-PYR1 double site mutants for yeast-based screens; redesigned to remove constitutive mutants and wild type rceptors

    Depositor

    Sean Cutler

    Article

    Tian et al bioRxiv [Preprint]. 2025 May 15:2025.05.

    Expression

    Yeast

    Species

    Arabidopsis thaliana

    Available Since

    Oct. 23, 2025

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV8)

    Viral Prep

    #20297-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (#20297). In addition to the viral particles, you will also receive purified pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA plasmid DNA. Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    EF1a

    Tags

    mCherry (Cre-dependent)

    Available Since

    Dec. 18, 2017

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV5)

    Viral Prep

    #20297-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (#20297). In addition to the viral particles, you will also receive purified pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA plasmid DNA. Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    EF1a

    Tags

    mCherry (Cre-dependent)

    Available Since

    Feb. 15, 2018

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV9)

    Viral Prep

    #20297-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (#20297). In addition to the viral particles, you will also receive purified pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA plasmid DNA. Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Promoter

    EF1a

    Tags

    mCherry (Cre-dependent)

    Available Since

    March 15, 2018

    Availability

    Academic Institutions and Nonprofits only